Phage therapy against Enterococcus faecalis in dental root canals

Article English OPEN
Leron Khalifa; Mor Shlezinger; Shaul Beyth; Yael Houri-Haddad; Shunit Coppenhagen-Glazer; Nurit Beyth; Ronen Hazan;
(2016)
  • Publisher: Co-Action Publishing
  • Journal: Journal of Oral Microbiology,volume 8 (issn: 2000-2297, eissn: 2000-2297)
  • Publisher copyright policies & self-archiving
  • Related identifiers: pmc: PMC5027333, doi: 10.3402/jom.v8.32157
  • Subject: dental biofilm | Medicine; Dentistry; Microbiology | Bacteriophages QW 161 | Review Article | RC109-216 | phage therapy | Infectious and parasitic diseases | Microbiology | QR1-502 | E. faecalis | Phage therapy, Enterococcus faecalis, biofilm, root canals
    mesheuropmc: biochemical phenomena, metabolism, and nutrition

Antibiotic resistance is an ever-growing problem faced by all major sectors of health care, including dentistry. Recurrent infections related to multidrug-resistant bacteria such as methicillin-resistant Staphylococcus aureus, carbapenem-resistant Enterobacteriaceae, an... View more
  • References (143)
    143 references, page 1 of 15

    1. Gradmann C. Re-inventing infectious disease: antibiotic resistance and drug development at the Bayer Company 1945 80. Med Hist 2016; 60: 155 80.

    2. Gradmann C. Magic bullets and moving targets: antibiotic resistance and experimental chemotherapy, 1900 1940. Dynamis 2011; 31: 305 21.

    3. Price NL, Goyette-Desjardins G, Nothaft H, Valguarnera E, Szymanski CM, Segura M, et al. Glycoengineered outer membrane vesicles: a novel platform for bacterial vaccines. Sci Rep 2016; 6: 24931.

    4. Drusano GL, Louie A, MacGowan A, Hope W. Suppression of emergence of resistance in pathogenic bacteria: keeping our powder dry. Part 1. Antimicrob Agents Chemother 2016; 60: 1183 93.

    5. Drusano GL, Hope W, MacGowan A, Louie A. Suppression of emergence of resistance in pathogenic bacteria: keeping our powder dry, Part 2. Antimicrob Agents Chemother 2016; 60: 1194 201.

    6. O'Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist 2015; 8: 217 30.

    7. Yarlagadda V, Sarkar P, Samaddar S, Haldar J. A vancomycin derivative with a Pyrophosphate-Binding Group: a strategy to combat vancomycin-resistant bacteria. Angew Chem Int Ed Engl 2016; 55: 7836 40.

    8. Feng Y, Jonker MJ, Moustakas I, Brul S, Ter Kuile BH. Dynamics of mutations during development of resistance by Pseudomonas aeruginosa against five antibiotics. Antimicrob Agents Chemother 2016; 60: 4229 36.

    9. Durai R, Ng PC, Hoque H. Methicillin-resistant Staphylococcus aureus: an update. Aorn J 2010; 91: 599 606; quiz 7 9.

    10. Emami S, Nikokar I, Ghasemi Y, Ebrahimpour M, Sedigh Ebrahim-Saraie H, Araghian A, et al. Antibiotic resistance pattern and distribution of pslA Gene among biofilm producing Pseudomonas aeruginosa isolated from waste water of a burn center. Jundishapur J Microbiol 2015; 8: e23669.

  • Metrics
Share - Bookmark